STUDY OF ARACHIDONIC ACID RELEASING STATUS IN DIABETIC RATS TREATED WITH FLAXSEED OIL

  • Jihan Hussein Medical Biochemistry Department, National Research Centre, Doki, Giza, Egypt
  • Zakaria El-khayat
  • Mohamed Moify

Abstract

Objective: Diabetes mellitus increased inflammation through stimulation of arachidonic acid liberation from the cell membranes which is transformed into actively cellular mediators such as thromboxanes, prostaglandins, and leukotrienes. So, this study aimed to investigate the effect of flaxseed oil as a source of omega 3 fatty acids on releasing of arachidonic acid from erythrocyte membrane and also on possible reduction of hyperhomocysteinemia during experimental diabetes.

Methods: Forty male albino rats were used in this study and divided into four groups: control, diabetic, flaxseed oil and treated groups. After the experimental period, blood samples were collected to estimate different biochemical parameters in plasma and in the erythrocyte membrane.

Results: The data showed the elevation of membrane arachidonic acid along with the elevation of inflammatory and oxidative stress markers in the diabetic group while flaxseed oil supplementation significantly decreased these levels.

Conclusion: We concluded that flaxseed oil is a promising supplement during diabetes mellitus due to its powerful effect in reducing arachidonic acid release and inhibition of hyperhomocysteinemia.

Keywords: flaxseed oil, Arachidonic acid, Hyperhomocysteinemia, Cell membrane, HPLC

Keywords: flaxseed oil, arachidonic acid, hyperhomocysteinemia, cell membrane, HPLC.

Downloads

Download data is not yet available.

References

1. Hussein J, El-Khayat Z, Morsy S, Oraby F, Singer G. The effect of fish oil on oxidant/antioxidant status in diabetic rats through the reduction of arachidonic acid in the cell membrane. Int J Pharm Pharm Sci 2014;6 Suppl 2:196-9.
2. Riccioni G, Bucciarelli T, Mancini B. Anti leukotriene drugs: clinical application, effectiveness, and safety. Curr Med Chem 2007;14:1966-77.
3. Sonkar SK, Soni D, Usman K. Plasma Homocysteine level and its clinical correlation with type 2 diabetes mellitus and its complications. Int J Diabetes Dev Countries 2014;34 Suppl 1:3–6.
4. Aukrust P, Liabakk NB, Muller F, Lien E, Espevik T, Froland SS. Serum levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection correlations to clinical, immunologic, and virologic parameters. J Infect Dis 1994;69:420-4.
5. Weylandt KH, Kang JX. Rethinking lipid mediators. Lancet 2005;366:618-20.
6. El-Khayat Z, Abo El-Matty D, Rasheed W, Hussein J, Shaker O, Raafat J. Role of cell membrane fatty acids in insulin sensitivity in diabetic rats treated with flaxseed oil. Int J Pharm Pharm Sci 2013;5 Suppl 2:146-51.
7. Uchiyama S, Yamaguchi M. Alteration in serum and bone component findings induced in streptozotocin-diabetic rats is restored by zinc acexamate. Int J Mol Med 2003;12:949-54.
8. Trinder P. Determination of glucose in blood using glucose oxidase with alternative oxygen acceptor. Ann Clin Biochem 1969;6:24-7.
9. Hussein J, Mostafa E, El-Waseef M, El-Khayat Z, Badawy E, Medhat D. Effect of omega-3 fatty acids on erythrocyte membrane in diabetic rats. Maced J Med Sci 2011;4 Suppl 3:234-9.
10. Beutler E, Duron O, Kelly BM. An improved method for the determination of blood glutathione. J Lab Clin Med 1963;61:882–8.
11. Uchiyamara M, Mihara M. Determination of malondialdehyde in tissue by thiobarbituric acid test. Anal Biochem 1978;86:271-8.
12. Yallow F, Bawman WA. Plasma insulin in health and disease. Diabetes Mellitus 1983;1:119-50.
13. Blight EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-5.
14. Hussein J, El-Khayat Z, Farrag AR, Medhat D, Abdel Latif Y, Oraby F. Inhibition of hyperhomocysteinemia in indomethacin-induced peptic ulcer: Impact of pomegranate juice supplementation. J Chem Pharm Res 2014;6 Suppl 10:131-8.
15. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001;294:1871-5.
16. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991;54:438–63.
17. Celotti F, Durand T. The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy. Prostaglandins Other Lipid Mediators 2003;71:147-62.
18. Riccioni G, Bucciarelli T, Mancini B. Antileukotriene drugs: clinical application, effectiveness, and safety. Curr Med Chem 2007;14:1966-77.
19. Healy DA, Wallace FA, Miles EA. Effect of low-to-moderate amounts of dietary fish oil on neutrophil lipid composition and function. Lipids 2000;35:763-8.
20. Calder PC. n-3 polyunsaturated fatty acids, inflammation and inflammatory diseases. Am J Clin Nutr 2006;83:1505S-19S.
Statistics
171 Views | 392 Downloads
How to Cite
Hussein, J., Z. El-khayat, and M. Moify. “STUDY OF ARACHIDONIC ACID RELEASING STATUS IN DIABETIC RATS TREATED WITH FLAXSEED OIL”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 8, no. 4, Apr. 2016, pp. 304-6, https://innovareacademics.in/journals/index.php/ijpps/article/view/10838.
Section
Original Article(s)